Literature DB >> 15599664

Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.

R Bertorello1, M P Cordone, P Contini, P Rossi, F Indiveri, F Puppo, G Cordone.   

Abstract

The aim of the study was to determine the levels of interleukin (IL)-10, IL-2, IL-4, and interferon-gamma in the saliva of patients with Sjögren's syndrome and to correlate them with laboratory and clinical parameters of disease activity. The levels of IL-2, IL-4, IL-10, and interferon-gamma were measured in salivary samples, obtained directly from the Stenone duct of 14 Sjögren's syndrome patients and 26 healthy controls by ELISA. A significant elevation of IL-10 was found in salivary fluids of Sjögren's syndrome patients compared with healthy controls (P=0.007). Elevated interferon-gamma levels were found in some patients. IL-2 and IL-4 were undetectable in all saliva samples. In patients, IL-10 levels significantly correlated with the degree of xerophthalmia and xerostomia (P=0.02 and P=0.01, respectively) and with the erythrocyte sedimentation rate (P=0.006). Our data suggest that elevated IL-10 levels are detectable in the saliva of Sjögren's syndrome patients and correlate with the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599664     DOI: 10.1007/s10238-004-0049-9

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  13 in total

Review 1.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

Review 2.  The T cell in Sjogren's syndrome: force majeure, not spectateur.

Authors:  Namrata Singh; Philip L Cohen
Journal:  J Autoimmun       Date:  2012-06-17       Impact factor: 7.094

3.  Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.

Authors:  Jean S Oak; Jonathan A Deane; Michael G Kharas; Ji Luo; Thomas E Lane; Lewis C Cantley; David A Fruman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

Review 4.  Cytokines in Sjögren's syndrome.

Authors:  N Roescher; P P Tak; G G Illei
Journal:  Oral Dis       Date:  2009-06-10       Impact factor: 3.511

5.  A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

Authors:  Sarah Benchabane; Abdelhalim Boudjelida; Ryma Toumi; Houda Belguendouz; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  Int J Immunopathol Pharmacol       Date:  2016-05-19       Impact factor: 3.219

6.  T Cell-Associated Cytokines in the Pathogenesis of Sjögren's Syndrome.

Authors:  Jun-O Jin; Qing Yu
Journal:  J Clin Cell Immunol       Date:  2013-02-26

Review 7.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

Review 8.  The association between TNF-α, IL-10 gene polymorphisms and primary Sjögren's syndrome: a meta-analysis and systemic review.

Authors:  Baodong Qin; Jiaqi Wang; Yan Liang; Zaixing Yang; Renqian Zhong
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

Review 9.  B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.

Authors:  Arne Hansen; Peter E Lipsky; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome.

Authors:  Yi-fan Huang; Qian Cheng; Chun-miao Jiang; Shu An; Lan Xiao; Yong-chao Gou; Wen-jing Yu; Lei Lei; Qian-ming Chen; Yating Wang; Jun Wang
Journal:  Clin Dev Immunol       Date:  2013-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.